This virtual course is designed for trainee and junior doctors working towards a career in any field of medicine where a medical emergency may be encountered.

This meeting will provide South West delegates with a useful opportunity to share the latest data, best practice and keep up to date with challenges in Acute Leukaemia. Suitable for consultants, trainees, CNS in both AML & ALL as well as pharmacists and scientists working in this disease area.

This virtual course is designed for consultants and other senior doctors working in any field of medicine where a medical emergency may be encountered.

This study day will focus on the recent advances seen within CLL, myeloma, lymphoma, rare and atypical myeloproliferations, myeloid and genomics and how diagnostic advances guide the individual patient pathway.

This non-malignant haematology update day will provide a review of the abstracts presented at the latest ISTH and ASH meetings which are most useful for UK practice.

This meeting will provide a comprehensive update on CAR-T cell therapy for haematology nurses and allied healthcare professionals.

This meeting will provide South West delegates with a useful opportunity to share latest data, best practice and keep up to date with changes in lymphoma practice.

Organiser and Chair: Professor Charles Craddock (Birmingham)
Co-Chairs: Dr Mike Dennis (Manchester) & Dr Steve Knapper (Cardiff)

This meeting will be held as a hybrid event, giving delegates the choice of attending in person or virtually. The programme consists of sessions covering TYA acute leukaemias, TYA MPN and chronic leukaemias, NHSE TYA service specification and non-malignant TYA haematology.

A day designed for a complete update on the diagnosis and treatment of Waldenstrom’s Macroglobulinemia. Topics that will appeal to consultant haematologists and CNS for a CPD educational day with UK and international experts on hand to address the issues and advances in 2021. This free of charge meeting is supported financially by a grant from BeiGene who have had no involvement in the choice of speakers or programme design.

This meeting will be held as a hybrid event, giving delegates the choice of attending in person or virtually. The programme includes talks from Prof Carsten Niemann (CLL-TIM), Prof Arnon Kater (Sequencing treatments in the era of novel agents), Dr William Wierda (CAR T cells in CLL) and lots more.

This Autumn meeting of the UK & Ireland Paediatric Bone Marrow Transplant Group will combine lectures from invited speakers and the annual audit meeting across centres, running virtually over the two days.

The Autumn Trainees Meeting represents a superb opportunity to communicate with and to learn from colleagues working in the full range of infection-related disciplines.

This virtual meeting, organised by the European Blood and Marrow Transplantation (United Kingdom) Nurses and Allied Professionals Group is open to all nurses and allied health professionals working within stem cell transplantation.

This meeting will include talks on CAR-T cell therapy in myeloma, COVID-19 vaccination, immunodeficiency (gene therapy and conditioning protocols), late effects of transplant, HLH, EBMT curriculum and education and more.

This hybrid event will give delegates the choice of attending in person or watching a live stream. The day will start with sessions on treatments and trials. The Terry Hamblin Memorial Lecture – The role of molecular genetics in the prognosis of MDS – will be delivered by Prof Elli Papaemmanuil and the day will end with clinical cases presentations.

The programme for this hybrid event has been planned to cover the breadth of MPN and closely related disorders with talks delivered by a panel of leading UK and international experts, including Tiziano Barbui, Jean Jacques Kiladjian and Serge Verstovsek. Delegates can choose to attend in person or to watch a live stream.

The theme of this hybrid meeting is Sequencing Therapy and Personalised Medicine in Myeloma. Delegates will be able to choose whether they prefer to attend in person or take in the day virtually.

This hybrid event will include sessions on living with risk, progress and controversies in lymphoma, acute myeloid leukaemia and myeloma: how do we treat it, as well as meet the expert case-based discussions. Delegates will have the choice of attending in person or virtually.

During this hybrid 2-day course, delegates will learn all aspects of CAR-T treatment, both clinical and administrative (quality assurance) with the hope that they can steer and lead similar programmes in their parent institute.

The day will start with talks on the launch of the new peer review standards, the upgraded and revamped NHR and a Covid-19 update, followed by a joint NHP/UKFHD session. The afternoon talks will be patient-focussed.

The programme for this meeting includes ‘Myeloma Question Time’ with a series of questions discussed by an expert panel and sessions on myeloma care in an ongoing COVID era, National Myeloma Registry and regional MDTs for CAR-T.

This day will include lectures and panel discussions from UK and international experts on topics such as keeping services going during COVID, chronic GVHD, dermatology, a ‘difficult cases’ MDT panel and a research project update from Professor Marcel van den Brink.

This virtual evening will combine case presentations with high calibre lectures and discussion to provide an update in the management of mantle cell lymphoma. Suitable for consultants, trainees, nurses, pharmacists and scientists working in this disease area.

Afternoon of ASH updates in CML, MPN, MF, thrombosis and ITP

Please contact carly@hartleytaylor.co.uk for enquiries about sponsorship

Variety of ASH updates in lymphoma, myeloma and leukaemia 

Please contact carly@hartleytaylor.co.uk for enquiries about sponsorship

Delegates will have a choice of attending day 1 of this preceptorship in person or virtually. Day 2 will be virtual for all. The course has been designed for healthcare professionals and clinical scientists interested in the management of infections in immunocompromised hosts.

This programme is designed to combine high calibre lectures and interactive discussions to provide an educational opportunity to update clinicians and allied professions in current issues within the management of diseases affecting haematology patients. Suitable for consultants, trainees, nurses, pharmacists and scientists working in haematology.